Forecast: Diabetes Medicine Use in Chile

The use of diabetes medicine in Chile has exhibited significant fluctuations from 2013 to 2023, with the most notable spike in 2020 where a 53.54% increase was observed. This trend peaked at 83.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2023. The annual growth rates demonstrate a highly variable trajectory, with sharp declines in 2016 and 2017, but the overall trend has been upward, particularly from 2020 onwards. The compound annual growth rate (CAGR) over the last 5 years stood at 11.86%, indicating robust growth in recent times.

For the future, from 2024 onwards, forecasts suggest steady growth with a 5-year forecasted CAGR of 3.4%, culminating in 104.0 Units in 2028. This points toward a less volatile but continued incremental increase in diabetes medicine consumption. Given this trend, stakeholders should monitor:

- Advances in diabetes treatment and medicine technology.

- Changes in healthcare policies and insurance coverage in Chile.

- Public health initiatives aimed at diabetes prevention and management.